The Alabama IVF ruling uses faux scientific language to justify a religious position
By David Sable,
STAT
| 02. 22. 2024
Imagine having 15 miscarriages.
Maybe you can shrug off the first one or two and keep trying to have children, to create a family. But soon every positive pregnancy test brings a sense of dread, of sad inevitability. Your body becomes your enemy.
In 1998, my group at Saint Barnabas Medical Center in suburban New Jersey was part of a team that developed a way to test for a genetic variant called a translocation, a swapping of parts of one chromosome with a different chromosome. For the most part, people with genetic translocations are completely fine; they have all of the same genes as anyone else. The problems arises when their cells have to split their chromosomes to make eggs or sperm, most of which have too much or little of some of the translocated genes. These unbalanced sperm and eggs create unbalanced embryos, which rarely develop past the second trimester.
By using fertility drugs to mature a number of eggs at once and fertilizing all of them, my colleagues and I were able to identify the small number of...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...